Warning letter
Fareva Amboise: warning letter of Apr 10, 2026
FDA warning letter 723502 · Center for Veterinary Medicine
Key facts
| Reference number | 723502 |
|---|---|
| Company | Fareva Amboise |
| Subject | CGMP/Finished Pharmaceuticals/Adulterated |
| Issue date | Apr 10, 2026 |
| Posted date | Jul 21, 2026 |
| Issuing office | Center for Veterinary Medicine |
| Product type | Veterinary |
| CFR sections cited | 211.68(b), 211.182, 211.63, 211.67, 211.67(a), 211.113(b) |
| Inspection city | Poce Sur Cisse |
| Inspection start date | Sep 8, 2025 |
| Letter on fda.gov | fda.gov |
At a glance
- 1–9 CFR sections cited
- OAI Linked inspection classification
- Yes Form FDA 483 issued
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA warning letters
FDA warning letters notify a firm of significant regulatory violations found during an inspection or review and request prompt corrective action.
Source: U.S. Food and Drug Administration (FDA), Warning Letters · Source date: